Seeds of Change Organic Quinoa, Brown & Red Rice
TINA.org reader flags main ingredient fail.
Ozempic, Wegovy, and Other GLP-1 RA Medications
Multiple class-action lawsuits regarding the marketing of GLP-1 RAs were transferred to be heard together as part of multidistrict litigation (MDL). More information on the MDL is below.
Case Name (Date)
In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
24-md-3094, E.D. Penn.
(2024)
Product/Service
Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Mounjaro, Zepbound, Trulicity and other GLP-1 RA medications
Allegations
Marketing products as weight-loss medications without adequately disclosing that many people stop using them due to their side effects, the medications do not result in meaningful weight loss for up to 15 percent of people, the average weight loss is approximately 10 percent of a person’s body weight, and people need to stay on them to maintain their weight loss
Status
Pending
The Latest
Dave ExtraCash Advance
What you should know about this fast cash offer.
Can You Tell Me How to Pay at Sesame Place?
Theme park fails to adequately disclose that it’s a “cashless” operation.
Nike: Rip The Script
It was all going to plan until footballer’s instincts took over.
Did Timothée Chalamet Just Take a Dig at Deceptive Marketing?
Why I’m a fan of this Adidas World Cup ad.